Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.61 (
caspase-8
)
6,833
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector C (
CIDEC
) is a potent apoptotic inducer. Previous studies have indicated that the Fat-specific protein 27 (Fsp27), a mouse homolog of
CIDEC
, induces apoptosis via caspase-3, -7, and -9 and triggers the release of cytochrome c from mitochondria, which implies that the mitochondrial pathway is involved in Fsp27-induced apoptosis. In the current study, we found that
CIDEC
-induced apoptosis was mediated by
caspase-8
. The caspase inhibitor assay showed that
CIDEC
-induced apoptosis was dramatically reduced in the presence of the general caspase inhibitor, the caspase-3 inhibitor, and the
caspase-8
inhibitor, whereas the caspase-9 inhibitor only weakly inhibited
CIDEC
-induced apoptosis. These results confirmed that the activation of caspase-3 and
caspase-8
were involved in
CIDEC
-induced apoptosis. Moreover, in caspase-3- or
caspase-8
-deficient cells,
CIDEC
-induced apoptosis were dramatically decreased, which demonstrated that
CIDEC
-induced apoptosis might require the activation of caspase-3 and
caspase-8
. Because
caspase-8
in general is a key effecter of death-receptor pathway and activated by Fas-Associated protein with Death Domain (FADD), we examined whether FADD was involved in
CIDEC
-induced apoptosis. Our results demonstrated that
CIDEC
-induced apoptosis was independent of FADD, suggesting that
CIDEC
-induced apoptosis might be in a death-receptor-independent,
caspase-8
-dependent manner. It was also found that the region of amino acid 168-200 in carboxyl domain of
CIDEC
was critical for its crucial pro-apoptotic function.
...
PMID:Human cell-death-inducing DFF45-like effector C induces apoptosis via caspase-8. 2186 23